美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=OMEPRAZOLE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
ESOMEPRAZOLE MAGNESIUM 216349 001 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE;ORAL EQ 20MG BASE No No 2022/06/24 2022/06/24 GRAVITI PHARMS Over-the-counter
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 204470 001 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;375MG No No 2022/08/24 2022/08/24 ACTAVIS LABS FL INC Discontinued
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 204470 002 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;500MG No No 2022/08/24 2022/08/24 ACTAVIS LABS FL INC Discontinued
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 213699 001 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;375MG No No 2022/10/06 2022/10/06 AJANTA PHARMA LTD Prescription
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 213699 002 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;500MG No No 2022/10/06 2022/10/06 AJANTA PHARMA LTD Prescription
ASPIRIN; OMEPRAZOLE 209791 001 ANDA ASPIRIN;OMEPRAZOLE TABLET;ORAL 81MG;40MG No No 2023/01/20 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
ASPIRIN; OMEPRAZOLE 209791 002 ANDA ASPIRIN;OMEPRAZOLE TABLET;ORAL 325MG;40MG No No 2023/01/20 (TA) -- TEVA PHARMS USA INC None (Tentative Approval)
ESOMEPRAZOLE MAGNESIUM 216149 001 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE;ORAL EQ 20MG BASE No No 2023/03/15 2023/03/15 GUARDIAN DRUG Over-the-counter
ESOMEPRAZOLE MAGNESIUM 214920 001 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 20MG BASE No No 2023/03/28 2023/03/28 PRINSTON INC Prescription
ESOMEPRAZOLE MAGNESIUM 214920 002 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 40MG BASE No No 2023/03/28 2023/03/28 PRINSTON INC Prescription
OMEPRAZOLE MAGNESIUM 213201 001 ANDA OMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE;ORAL EQ 20MG BASE No No 2023/04/28 2023/04/28 AUROBINDO PHARMA LTD Discontinued
ESOMEPRAZOLE MAGNESIUM 206055 001 ANDA ESOMEPRAZOLE MAGNESIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 20MG BASE/PACKET No No 2023/06/07 2023/06/07 ZYDUS PHARMS Prescription
ESOMEPRAZOLE MAGNESIUM 206055 002 ANDA ESOMEPRAZOLE MAGNESIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE/PACKET No No 2023/06/07 2023/06/07 ZYDUS PHARMS Prescription
ESOMEPRAZOLE MAGNESIUM 214473 001 ANDA ESOMEPRAZOLE MAGNESIUM TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE No No 2023/07/12 2023/07/12 AUROBINDO PHARMA LTD Discontinued
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 217738 001 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;375MG No No 2023/10/11 2023/10/11 SCIEGEN PHARMS INC Prescription
NAPROXEN AND ESOMEPRAZOLE MAGNESIUM 217738 002 ANDA ESOMEPRAZOLE MAGNESIUM; NAPROXEN TABLET, DELAYED RELEASE;ORAL EQ 20MG BASE;500MG No No 2023/10/11 2023/10/11 SCIEGEN PHARMS INC Prescription
ESOMEPRAZOLE MAGNESIUM 217427 001 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 20MG BASE No No 2023/10/18 2023/10/18 GRANULES Prescription
ESOMEPRAZOLE MAGNESIUM 217427 002 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 40MG BASE No No 2023/10/18 2023/10/18 GRANULES Prescription
ESOMEPRAZOLE MAGNESIUM 217022 001 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 20MG BASE No No 2023/12/27 2023/12/27 ZHEJIANG YONGTAI Prescription
ESOMEPRAZOLE MAGNESIUM 217022 002 ANDA ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL EQ 40MG BASE No No 2023/12/27 2023/12/27 ZHEJIANG YONGTAI Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database